ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
How to invest
What I'd buy if I wanted to turn $10,000 into $100,000 with ASX shares
Growth Shares
3 ASX 200 stocks I'd buy and hold for the next 10 years
Blue Chip Shares
3 quality ASX shares to buy before the market rebounds
Healthcare Shares
Why I'm taking a closer look at ResMed shares
Healthcare Shares
Trump 2.0: Macquarie's take on the winners and losers in Australian healthcare
Broker Notes
Where to invest $10,000 in ASX shares after the market selloff
How to invest
If I were building my portfolio from scratch, I'd buy these 3 ASX stocks today
Broker Notes
2 top quality ASX 200 shares to buy after the market selloff
How to invest
Here's a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!
Broker Notes
10 ASX shares to buy after the market selloff
Healthcare Shares
Should I buy Fisher & Paykel or ResMed shares?
Growth Shares
5 of the best ASX shares to buy after the market selloff
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
